United Therapeutics
Price & Volume
Stats
See moreOpen | $475.62 |
Previous Close | $472.21 |
Day Range | $471.50-$479.93 |
52W Range | $409.07-$609.35 |
Market Cap | $20.2B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $3.1B |
Revenue Growth (YoY) | -1.9% |
Gross Profit (12 Mos) | $2.7B |
Diluted EPS | $26.92 |
News
See moreYahoo Finance • 7 days ago
Biotech Options Buzz: UTHR, NMRA, EWTX
Yahoo Finance • 14 days ago
Why Is Altimmune (ALT) Up 14.2% Since Last Earnings Report?
Yahoo Finance • 18 days ago
Assessment of the Pulmonary Arterial Hypertension (PAH) Market 2026-2036 Featuring United Therapeutics, Mochida Pharmaceutical, Johnson & Johnson, Merck, and Gossamer Bio
Yahoo Finance • 23 days ago
3 Profitable Stocks We’re Skeptical Of
About
CEO | Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D. |
CFO | Mr. James C. Edgemond |
Address | 1000 Spring Street, Silver Spring, MD, United States, 20910 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 1,400 |